Plasma homocysteine and the risk of venous thromboembolism: insights from the FIELD study

Abstract

Hyperhomocysteinemia is prospectively associated with VTE. Fenofibrate may predispose individuals with high pretreatment HCY towards VTE. The fenofibrate induced increase in HCY did not, however, explain the risk associated with fenofibrate therapy.